Citizen Petition from Pharmaceutical Safety Oversight Council
Details
The document's own metadata, straight from the source system.
- Title
- Citizen Petition from Pharmaceutical Safety Oversight Council
- Posted
- Jun 3, 2026
- Comment period
- Jun 3, 2026 – ?
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Stance breakdown
Who commented
Breakdown by commenter type.
Comments over time
Weekly arrivals, stacked by stance.
Support × commenter type
How each type splits across stance.
Issues raised
The docket's canonical issues. Select one to browse its comments.
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
- 4 comments from the past week
4 comments match your current view and arrived in the last week. Read this week's comments with stance, commenter type, and AI summaries on the paid plan.
- Jul 27, 2026Comment from Bridges KaylaAnalysis pending📎 AttachmentRead comment →
- Jul 26, 2026Comment from Bollmann CarrieSupportIndividualRead comment →
- Jul 25, 2026Comment from Stith Burdette SarahAnalysis pending📎 AttachmentRead comment →
- Jul 25, 2026Comment from Plummer ChrisSupportIndividual
The commenter is a pet owner who shares a personal story about their dog's severe adverse reactions to the drug Librela. They are urging the agency to remove the product from the market or issue a warning to veterinarians and owners.
Read comment → - Jul 25, 2026Comment from Shirley TiffanyAnalysis pending📎 AttachmentRead comment →
- Jul 24, 2026Comment from Mciver LouisaSupportIndividual
An individual is sharing a personal anecdote about their dog suffering a severe adverse reaction (seizures) after receiving a Librela injection. By providing this testimony in response to a petition regarding pharmaceutical safety oversight, the commenter supports the action of increased oversight.
Read comment → - Jul 24, 2026Comment from Paine SusanSupportIndividual
An individual pet owner shares a personal account of their dog's death following the administration of Librela, citing severe adverse reactions. The commenter supports the petition by highlighting the dangers of the medication and the lack of transparency regarding side effects.
Read comment → - Jul 23, 2026Comment from Brittain BrendaSupportIndividual
A pet owner is requesting the recall of the anti-NGF monoclonal antibody injection Librela after their dog died following its administration. The commenter argues that the drug is dangerous and deadly, citing severe adverse reactions and necropsy results as evidence.
Read comment → - Jul 20, 2026Comment from Biancalana TraciSupportIndividualRead comment →
- Jul 20, 2026Comment from AnonymousSupportIndividualRead comment →